Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is it? Response to an Editorial

Editorial Material Orthopedics

Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?

Javad Parvizi et al.

JOURNAL OF ARTHROPLASTY (2023)

添加到收藏夹

Article Orthopedics

Recommendations from the ICM-VTE: Hip & Knee

[Anonymous]

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Thromboprophylaxis After Hip or Knee Arthroplasty

Noel C. Chan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial

Yi Ren et al.

Summary: The study found that the prophylactic use of 100 mg aspirin twice daily was not statistically different from that of rivaroxaban in preventing venous thromboembolism (VTE) and reducing the risk of blood loss following elective primary total hip arthroplasty (THA). This supports aspirin as a less expensive and more widely available option for future THAs.

CHINESE MEDICAL JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

W. S. Jones et al.

Summary: In a pragmatic trial involving patients with established cardiovascular disease, no significant differences were found in cardiovascular events or major bleeding between patients assigned to daily 81 mg and those assigned to 325 mg of aspirin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Orthopedics